AAAAAA
Results: 26-50/67
Authors:
Tanner, MM
Grenman, S
Koul, A
Johannsson, O
Meltzer, P
Pejovic, T
Borg, A
Isola, JJ
Citation: Mm. Tanner et al., Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer, CLIN CANC R, 6(5), 2000, pp. 1833-1839
Authors:
Koul, A
Malander, S
Loman, N
Pejovic, T
Heim, S
Willen, R
Johannson, O
Olsson, H
Ridderheim, M
Borg, A
Citation: A. Koul et al., BRCA1 and BRCA2 mutations in ovarian cancer: Covariation with specific cytogenetic features, INT J GYN C, 10(4), 2000, pp. 289-295
Authors:
Planck, M
Wenngren, E
Borg, A
Olsson, H
Nilbert, M
Citation: M. Planck et al., Somatic frameshift alterations in mononucleotide repeat-containing genes in different tumor types from an HNPCC family with germline MSH2 mutation, GENE CHROM, 29(1), 2000, pp. 33-39
Authors:
Staff, S
Nupponen, NN
Borg, A
Isola, JJ
Tanner, MM
Citation: S. Staff et al., Multiple copies of mutant BRCA1 and BRCA2 alleles in breast tumors from germ-line mutation carriers, GENE CHROM, 28(4), 2000, pp. 432-442
Authors:
Sarantaus, L
Huusko, P
Eerola, H
Launonen, V
Vehmanen, P
Rapakko, K
Gillanders, E
Syrjakoski, K
Kainu, T
Vahteristo, P
Krahe, R
Paakkonen, K
Hartikainen, J
Blomqvist, C
Lopponen, T
Holli, K
Ryynanen, M
Butzow, R
Borg, A
Arver, BW
Holmberg, E
Mannermaa, A
Kere, J
Kallioniemi, OP
Winqvist, R
Nevanlinna, H
Citation: L. Sarantaus et al., Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland, EUR J HUM G, 8(10), 2000, pp. 757-763
Authors:
Jonsson, M
Borg, A
Nilbert, M
Andersson, T
Citation: M. Jonsson et al., Involvement of adenomatous polyposis coli (APC)/beta-catenin signalling inhuman breast cancer, EUR J CANC, 36(2), 2000, pp. 242-248
Authors:
Loman, N
Johannsson, A
Bendahl, PO
Dahl, N
Einbeigi, Z
Gerdes, AM
Borg, A
Olsson, H
Citation: N. Loman et al., Prognosis and clinical presentation of BRCA2-associated breast cancer, EUR J CANC, 36(11), 2000, pp. 1365-1373
Authors:
Stal, O
Borg, A
Ferno, M
Kallstrom, AC
Malmstrom, P
Nordenskjold, B
Citation: O. Stal et al., ErbB2 status and the benefit from two or five years of adjuvant tamoxifen in postmenopausal early stage breast cancer, ANN ONCOL, 11(12), 2000, pp. 1545-1550
Authors:
Adeyinka, A
Mertens, F
Bondeson, L
Garne, JP
Borg, A
Baldetorp, B
Pandis, N
Citation: A. Adeyinka et al., Cytogenetic heterogeneity and clonal evolution in synchronous bilateral breast carcinomas and their lymph node metastases from a male patient withoutany detectable BRCA2 germline mutation, CANC GENET, 118(1), 2000, pp. 42-47
Authors:
Ramstad, A
Strisland, F
Ramsvik, T
Borg, A
Citation: A. Ramstad et al., CO adsorption on the Pt/Rh(100) surface studied by high-resolution photoemission, SURF SCI, 458(1-3), 2000, pp. 135-146
Authors:
Kainu, T
Juo, SHH
Desper, R
Schaffer, AA
Gillanders, E
Rozenblum, E
Freas-Lutz, D
Weaver, D
Stephan, D
Bailey-Wilson, J
Kallioniemi, OP
Tirkkonen, M
Syrjakoski, K
Kuukasjarvi, T
Koivisto, P
Karhu, R
Holli, K
Arason, A
Johannesdottir, G
Bergthorsson, JT
Johannsdottir, H
Egilsson, V
Barkardottir, RB
Johannsson, O
Haraldsson, K
Sandberg, T
Holmberg, E
Gronberg, H
Olsson, H
Borg, A
Vehmanen, P
Eerola, H
Heikkila, P
Pyrhonen, S
Nevanlinna, H
Citation: T. Kainu et al., Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus, P NAS US, 97(17), 2000, pp. 9603-9608
Authors:
Borg, A
Isola, J
Chen, JD
Rubio, C
Johansson, U
Werelius, B
Lindblom, A
Citation: A. Borg et al., Germline BRCAl and hMLHl mutations in a family with male and female breastcarcinoma, INT J CANC, 85(6), 2000, pp. 796-800
Authors:
Borg, A
Citation: A. Borg, The metropolis and its image: Constructing identities for London, c.1750-1950, ENGLISH HIS, 115(462), 2000, pp. 741-742
Authors:
Kauraniemi, P
Hedenfalk, I
Persson, K
Duggan, DJ
Tanner, M
Johannsson, O
Olsson, H
Trent, JM
Isola, J
Borg, A
Citation: P. Kauraniemi et al., MYB oncogene amplification in hereditary BRCA1 breast cancer, CANCER RES, 60(19), 2000, pp. 5323-5328
Authors:
Fuqua, SAW
Wiltschke, C
Zhang, QX
Borg, A
Castles, CG
Friedrichs, WE
Hopp, T
Hilsenbeck, S
Mohsin, S
O'Connell, P
Allred, DC
Citation: Saw. Fuqua et al., A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions, CANCER RES, 60(15), 2000, pp. 4026-4029
Authors:
Mineta, H
Miura, K
Ogino, T
Takebayashi, S
Misawa, K
Ueda, Y
Suzuki, I
Dictor, M
Borg, A
Wennerberg, J
Citation: H. Mineta et al., Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas, BR J CANC, 83(6), 2000, pp. 775-781
Authors:
Jarvinen, TAH
Tanner, M
Rantanen, V
Barlund, M
Borg, A
Grenman, S
Isola, J
Citation: Tah. Jarvinen et al., Amplification and deletion of topoisomerase II alpha associate with ErbB-2amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer, AM J PATH, 156(3), 2000, pp. 839-847
Authors:
Moses, EK
Lade, JA
Guo, GL
Wilton, AN
Grehan, M
Freed, K
Borg, A
Terwilliger, JD
North, R
Cooper, DW
Brennecke, SP
Citation: Ek. Moses et al., A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2, AM J HU GEN, 67(6), 2000, pp. 1581-1585
Authors:
Mazoyer, S
Leary, J
Kirk, J
Fleischmann, E
Wagner, T
Claes, K
Messiaen, L
Foulkes, W
Desrochers, M
Simard, J
Phelan, CM
Kwan, E
Narod, SA
Vahteristo, P
Nevanlinna, H
Durando, X
Bignon, YJ
Peyrat, JP
Bonnardel, C
Sinilnikova, OM
Puget, N
Lenoir, GM
Mazoyer, S
Audoynaud, C
Goldgar, D
Maugard, C
Caux, V
Gad, S
Stoppa-Lyonnet, D
Nogues, C
Lidereau, R
Machavoine, C
Bressac-de Paillerets, B
Kuschel, B
Betz, B
Niederacher, D
Beckmann, MW
Hamann, U
Gayther, SA
Ponder, BAP
Robinson, M
Taylor, GR
Bishop, T
Catteau, A
Solomon, E
Cohen, B
Steel, M
Collins, N
Stratton, M
van der Looij, M
Olah, E
Miller, NJ
Barton, DE
Sverdlov, RS
Friedman, E
Radice, P
Montagna, M
Sensi, E
Caligo, M
van Eijk, R
Devilee, P
van der Luijt, R
Heimdal, K
Moller, P
Borg, A
Diez, O
Cortes, J
Domenech, M
Baiget, M
Osorio, A
Benitez, J
Borg, A
Maillet, P
Sappino, AP
Ozdag, H
Ozcelik, T
Ozturk, M
Rohlfs, EM
Boyd, J
McDermott, D
Offit, K
Unger, M
Nathanson, K
Weber, BL
Sellers, TA
Hampton, E
Couch, FJ
Neuhausen, S
Citation: S. Mazoyer et al., The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations, AM J HU GEN, 67(1), 2000, pp. 207-212
Authors:
Jarvinen, TAH
Tanner, M
Barlund, M
Borg, A
Isola, J
Citation: Tah. Jarvinen et al., Characterization of topoisomerase II alpha gene amplification and deletionin breast cancer, GENE CHROM, 26(2), 1999, pp. 142-150
Authors:
Laake, K
Launonen, V
Niederacher, D
Gudlaugsdottir, S
Seitz, S
Rio, P
Champeme, MH
Bieche, I
Birnbaum, D
White, G
Sztan, M
Sever, N
Plummer, S
Osorio, A
Broeks, A
Huusko, P
Spurr, N
Borg, A
Cleton-Jansen, AM
van't Veer, L
Benitez, J
Casey, G
Peterlin, B
Olah, E
Varley, J
Bignon, YJ
Scherneck, S
Sigurdardottir, V
Lidereau, R
Eyfjord, J
Beckmann, MW
Winqvist, R
Skovlund, E
Borresen-Dale, AL
Citation: K. Laake et al., Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study, GENE CHROM, 25(3), 1999, pp. 212-221
Authors:
Persson, K
Pandis, N
Mertens, F
Borg, A
Baldetorp, B
Killander, D
Isola, J
Citation: K. Persson et al., Chromosomal aberrations in breast cancer: A comparison between cytogenetics and comparative genomic hybridization, GENE CHROM, 25(2), 1999, pp. 115-122
Authors:
Koul, A
Nilbert, M
Borg, A
Citation: A. Koul et al., A somatic BRCA2 mutation in RER+ endometrial carcinomas that specifically deletes the amino-terminal transactivation domain, GENE CHROM, 24(3), 1999, pp. 207-212
Authors:
Johannsson, O
Loman, N
Moller, T
Kristoffersson, U
Borg, A
Olsson, H
Citation: O. Johannsson et al., Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers, EUR J CANC, 35(8), 1999, pp. 1248-1257
Authors:
Nilbert, M
Planck, M
Fernebro, E
Borg, A
Johnson, A
Citation: M. Nilbert et al., Microsatellite instability is rare in rectal carcinomas and signifies hereditary cancer, EUR J CANC, 35(6), 1999, pp. 942-945